Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 110.00
Ask: 115.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.545%)
Open: 112.50
High: 114.00
Low: 112.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Regulatory Approval

22 Jan 2018 07:00

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES UKRANIAN MARKETING AUTHORISATIONS FOR AIVLOSIN® FOR PIGS AND POULTRY

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a number of marketing authorisations for Aivlosin® from the Department for Food Safety and Veterinary from the State Service of Ukraine on Food Safety and Consumer Protection.

Aivlosin ® , ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

These authorisations, which are for the use of Aivlosin® 625 mg/g water soluble granules and Aivlosin® 42.5 mg/g premix for both pigs and poultry, also allow ECO to start selling Aivlosin® in the Ukraine for the medication of drinking water or for mixing into feed, for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.

These new treatments meet all the guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, these treatments are under the control of veterinarians, available under prescription only and have low, highly effective therapeutic dose rates, a short treatment duration and a zero day or very short drug withholding period.

Peter Lawrence, Chairman of ECO, commented “We are extremely pleased to receive these marketing authorisations for Aivlosin® in the Ukraine, the sixteenth largest egg producing country and one that is ranked just outside the top twenty globally for pork production.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence   020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
 

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

View source version on businesswire.com: http://www.businesswire.com/news/home/20180121005079/en/

Copyright Business Wire 2018

Date   Source Headline
1st Feb 20181:33 pmBUSBlock listing Interim Review
1st Feb 20181:24 pmBUSTotal Voting Rights
23rd Jan 20183:37 pmBUSDirector/PDMR Shareholding
22nd Jan 20187:00 amBUSRegulatory Approval
5th Jan 20187:00 amBUSCirc re. Change of Nominated Adviser
19th Dec 20177:00 amBUSRegulatory Approval
13th Dec 20177:00 amBUSRegulatory Approval
6th Dec 20177:00 amBUSHalf-year Report
1st Dec 20177:00 amBUSDirectorate change
2nd Nov 20173:20 pmBUSBlock listing Interim Review - Replacement
25th Sep 20173:42 pmBUSHolding(s) in Company
22nd Sep 20178:53 amBUSHolding(s) in Company
20th Sep 20178:04 amBUSAGM Statement
4th Sep 20173:12 pmBUSTotal Voting Rights
23rd Aug 20178:30 amBUSDirector/PDMR Shareholding
21st Aug 20177:00 amBUSRegulatory Approval
15th Aug 20174:48 pmBUSDirector/PDMR Shareholding
14th Aug 20177:00 amBUSRegulatory Approval
1st Aug 20177:00 amBUSTotal Voting Rights
1st Aug 20177:00 amBUSCirc re. Block listing return
24th Jul 20177:00 amBUSRegulatory Approval
19th Jul 201711:05 amBUSDoc re. Block Listing Application
11th Jul 201710:11 amBUSHolding(s) in Company
11th Jul 201710:04 amBUSHolding(s) in Company
3rd Jul 20172:26 pmBUSNotice of AGM
30th Jun 20172:56 pmBUSDirector/PDMR Shareholding
30th Jun 20177:00 amBUSFinal Results
5th Jun 20177:00 amBUSRegulatory Approval
15th May 20177:00 amBUSTrading Statement
13th Mar 20179:32 amBUSHolding(s) in Company
2nd Feb 20178:29 amBUSHolding(s) in Company
20th Jan 20173:59 pmBUSHolding(s) in Company
20th Jan 20173:56 pmBUSHolding(s) in Company
12th Jan 20173:05 pmBUSDirector/PDMR Shareholding
9th Jan 20177:00 amBUSRegulatory Approval
19th Dec 201610:42 amBUSDirector/PDMR Shareholding
12th Dec 20167:00 amBUSHalf-year Report
5th Dec 20167:00 amBUSRegulatory Approval
2nd Nov 201610:06 amBUSHolding(s) in Company
1st Nov 201610:23 amBUSCirc re.Appointment of Joint Broker
31st Oct 201612:55 pmBUSDirector/PDMR Shareholding
31st Oct 20169:00 amBUSHolding(s) in Company
19th Oct 20167:00 amBUSRegulatory Approval
13th Oct 20164:24 pmBUSDirector/PDMR Shareholding
6th Oct 20167:46 amBUSDirector/PDMR Shareholding
28th Sep 20163:44 pmBUSDirector/PDMR Shareholding
16th Sep 201612:47 pmBUSAGM Statement
16th Sep 20167:00 amBUSAGM Statement
15th Sep 20163:57 pmBUSDirector/PDMR Shareholding
9th Sep 20168:19 amBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.